27 May 2025
// ECONOMICTIMES
22 May 2025
// INDPHARMAPOST
21 May 2025
// FDA
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
About
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Industry Trade Show
Attending
04-06 September, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #3.1G6
28-30 October, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Industry Trade Show
Attending
04-06 September, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Booth #3.1G6
28-30 October, 2025
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/novartis-gsk-sanofi-bms-shell-out-over-us-10-bn-in-dealmaking-as-mid-size-deals-take-centerstage-in-2024
27 May 2025
// ECONOMICTIMES
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-offers-payment-plan-for-high-cost-heart-medicine/articleshow/121421067.cms
22 May 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/mankind-pharma-posts-q4-fy25-consolidated-pat-rs-42511-cr-17186
21 May 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219136
03 Apr 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/mankind-unveils-healthoks-100-vegetarian-multivitamin-tablets-campaign-with-archana-puran-singh-16968
27 Jan 2025
// PRESS FRELEASE
https://www.mankindpharma.com/media/press-release/mankind-pharma-launches-45-day-healthcare-mission-at-mahakumbh-serving-thousands-of-pilgrims-with-free-health-check-ups
24 Jan 2025
// BUSINESS STD
https://www.business-standard.com/markets/capital-market-news/mankind-pharma-slides-after-q3-pat-slips-16-yoy-to-rs-380-cr-125012400521_1.html
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-12
Pay. Date : 2021-11-29
DMF Number : 34844
Submission : 2020-06-05
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-08-20
Pay. Date : 2020-07-21
DMF Number : 34935
Submission : 2020-07-30
Status : Active
Type : II
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-01-21
Pay. Date : 2019-11-14
DMF Number : 34190
Submission : 2019-11-22
Status : Active
Type : II
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-03-30
Pay. Date : 2020-02-20
DMF Number : 34353
Submission : 2020-02-26
Status : Active
Type : II
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-26
Pay. Date : 2019-03-05
DMF Number : 33351
Submission : 2018-12-28
Status : Active
Type : II
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-26
Pay. Date : 2019-03-05
DMF Number : 33523
Submission : 2019-02-23
Status : Active
Type : II
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-12-31
Pay. Date : 2020-12-07
DMF Number : 35357
Submission : 2020-12-07
Status : Active
Type : II
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-06-16
Pay. Date : 2021-03-24
DMF Number : 35635
Submission : 2021-03-05
Status : Active
Type : II
Available Reg. Filing : ASMF |
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-10-15
Pay. Date : 2020-09-16
DMF Number : 34571
Submission : 2020-03-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-10-18
Pay. Date : 2021-09-08
DMF Number : 35702
Submission : 2021-03-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-01-12
Pay. Date : 2021-11-29
DMF Number : 34844
Submission : 2020-06-05
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36365
Submission : 2021-09-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-06-21
Pay. Date : 2022-06-01
DMF Number : 37011
Submission : 2022-04-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39328
Submission : 2024-05-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-08-20
Pay. Date : 2020-07-21
DMF Number : 34935
Submission : 2020-07-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37540
Submission : 2023-02-01
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-30
Pay. Date : 2020-02-20
DMF Number : 34353
Submission : 2020-02-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-01-21
Pay. Date : 2019-11-14
DMF Number : 34190
Submission : 2019-11-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2025-01-16
Pay. Date : 2025-01-06
DMF Number : 40408
Submission : 2024-11-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-04-26
Pay. Date : 2019-03-05
DMF Number : 33523
Submission : 2019-02-23
Status : Active
Type : II
Registrant Name : Lihu Healthcare Co., Ltd.
Registration Date : 2023-01-27
Registration Number : Su382-8-ND
Manufacturer Name : Mankind Pharma Limited@Shree J...
Manufacturer Address : 208, Okhla Industrial Estate, Phase-3, New Delhi-110020, India@C-24 &25, RIICO Indust...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical company in 1995. ...
Details:
Mankind pharma launched Molulife (Molnupiravir) developed by MSD and Ridgeback Biotherapeutics by next week, It is also expected that Cipla, Sun pharma, and DRL will also release Molnupiravir in the coming weeks for the treatment of patients with severe COVID19.
Lead Product(s): Molnupiravir
Therapeutic Area: Infections and Infectious Diseases Brand Name: Molulife
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 01, 2022
Lead Product(s) : Molnupiravir
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Mankind pharma launched Molulife (Molnupiravir) developed by MSD and Ridgeback Biotherapeutics by next week, It is also expected that Cipla, Sun pharma, and DRL will also release Molnupiravir in the coming weeks for the treatment of patients with severe ...
Product Name : Molulife
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 01, 2022
Details:
The top selling brands are Pangraf (tacrolimus), Alphadol (alfacalcidol), Cilamin (penicillamine) & Livoluk Fibre (lactulose in combination with ispaghula) were ranked number 1, whereas Glizid (Gliclazide + Metformin), Mycept (Mycophenolate Mofetil) were among the top 5.
Lead Product(s): Tacrolimus
Therapeutic Area: Dermatology Brand Name: Pangraf
Study Phase: Approved FDFProduct Type: Antibiotic
Sponsor: Panacea Biotec Limited
Deal Size: $251.1 million Upfront Cash: Undisclosed
Deal Type: Agreement January 02, 2022
Lead Product(s) : Tacrolimus
Therapeutic Area : Dermatology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Panacea Biotec Limited
Deal Size : $251.1 million
Deal Type : Agreement
Panacea Biotec Sells Domestic Formulation Assets To Mankind Pharma for Rs 1,908 Crore
Details : The top selling brands are Pangraf (tacrolimus), Alphadol (alfacalcidol), Cilamin (penicillamine) & Livoluk Fibre (lactulose in combination with ispaghula) were ranked number 1, whereas Glizid (Gliclazide + Metformin), Mycept (Mycophenolate Mofetil) were...
Product Name : Pangraf
Product Type : Antibiotic
Upfront Cash : Undisclosed
January 02, 2022
Details:
Posaconazole has been found to be a safer and effective drug of choice for the management of the disease. The drug has received approval from the Drug Controller General of India (DCGI).
Lead Product(s): Posaconazole
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 06, 2021
Lead Product(s) : Posaconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Mankind Pharma Launches Drug to Treat Black Fungus
Details : Posaconazole has been found to be a safer and effective drug of choice for the management of the disease. The drug has received approval from the Drug Controller General of India (DCGI).
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 06, 2021
Details:
2-DG (2-deoxy-D-glucose) is approved and is indicated as an adjunct treatment for patienst siffering from moderate to severe Covid-19.
Lead Product(s): 2-Deoxy-D-Glucose
Therapeutic Area: Infections and Infectious Diseases Brand Name: 2-DG
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 08, 2021
Lead Product(s) : 2-Deoxy-D-Glucose
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Mankind Pharma Gets DRDO Nod to Manufacture, Market Covid Drug 2-DG
Details : 2-DG (2-deoxy-D-glucose) is approved and is indicated as an adjunct treatment for patienst siffering from moderate to severe Covid-19.
Product Name : 2-DG
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 08, 2021
Details:
Mankind Pharma has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat diabetes, heart failure and chronic kidney disease. Launching API DMF grade dapagliflozin is an innovative futuristic approach to provide the best in class quality to the patients.
Lead Product(s): Dapagliflozin
Therapeutic Area: Endocrinology Brand Name: Justoza
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 22, 2021
Lead Product(s) : Dapagliflozin
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Mankind Pharma Launches Justoza to Treat Diabetes, Heart Failure & CKD
Details : Mankind Pharma has launched Justoza, a Dapagliflozin brand marketed by Mankind to treat diabetes, heart failure and chronic kidney disease. Launching API DMF grade dapagliflozin is an innovative futuristic approach to provide the best in class quality to...
Product Name : Justoza
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 22, 2021
Details:
MKP10241, a new class of anti-diabetic molecules, is designed and developed at the Mankind Research Centre. It is a potent and orally administered small molecule, GPR119 agonist. GPR 119 is highly expressed in pancreatic beta cells and intestinal enteroendocrine cells.
Lead Product(s): MKP10241
Therapeutic Area: Endocrinology Brand Name: MKP10241
Study Phase: PreclinicalProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 19, 2021
Lead Product(s) : MKP10241
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Mankind Pharma Gets CDSCO Panel Nod for Phase I Trial of Anti-Diabetic Drug, MKP10241
Details : MKP10241, a new class of anti-diabetic molecules, is designed and developed at the Mankind Research Centre. It is a potent and orally administered small molecule, GPR119 agonist. GPR 119 is highly expressed in pancreatic beta cells and intestinal enteroe...
Product Name : MKP10241
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 19, 2021
Details:
Company announced that new data from clinical studies of Afrezza® demostrating safe and effective dosing, its association with weight loss in patients with type 2 diabetes, and an evaluation of a comprehensive two year safety study showing that significant changes in FEV1.
Lead Product(s): Technosphere Insulin
Therapeutic Area: Endocrinology Brand Name: Afrezza
Study Phase: Approved FDFProduct Type: Hormone
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 15, 2020
Lead Product(s) : Technosphere Insulin
Therapeutic Area : Endocrinology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ManKind Presents Positive Original Analyses of Afrezza® Clinical Data at American Diabetes Associ...
Details : Company announced that new data from clinical studies of Afrezza® demostrating safe and effective dosing, its association with weight loss in patients with type 2 diabetes, and an evaluation of a comprehensive two year safety study showing that signific...
Product Name : Afrezza
Product Type : Hormone
Upfront Cash : Inapplicable
June 15, 2020
Inspections and registrations
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-04-13
City : Imt Manesar
State : Haryana
Country/Area : India
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2023-04-13
District Decision : Voluntary Action Indicated
Inspection End Date : 2022-02-25
City : Paonta Sahib
State :
Country/Area : India
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2022-02-25
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-01-11
City : Paonta Sahib
State :
Country/Area : India
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-01-11
ABOUT THIS PAGE
Mankind Pharma is a supplier offers 43 products (APIs, Excipients or Intermediates).
Find a price of Atorvastatin bulk with DMF offered by Mankind Pharma
Find a price of Baclofen bulk with DMF offered by Mankind Pharma
Find a price of Cilnidipine bulk with DMF offered by Mankind Pharma
Find a price of Clomipramine Hydrochloride bulk with DMF offered by Mankind Pharma
Find a price of Clozapine bulk with DMF offered by Mankind Pharma
Find a price of Haloperidol bulk with DMF offered by Mankind Pharma
Find a price of Haloperidol Decanoate bulk with DMF offered by Mankind Pharma
Find a price of Midodrine bulk with DMF offered by Mankind Pharma
Find a price of Nitrofurantoin bulk with DMF offered by Mankind Pharma
Find a price of Pantoprazole Sodium bulk with DMF offered by Mankind Pharma
Find a price of Propranolol Hydrochloride bulk with DMF offered by Mankind Pharma
Find a price of Ranolazine bulk with DMF offered by Mankind Pharma
Find a price of Revefenacin bulk with DMF offered by Mankind Pharma
Find a price of Rocuronium Bromide bulk with DMF offered by Mankind Pharma
Find a price of Rosuvastatin Calcium bulk with DMF offered by Mankind Pharma
Find a price of Sacubitril Sodium bulk with DMF offered by Mankind Pharma
Find a price of Sacubitril-Valsartan bulk with DMF offered by Mankind Pharma
Find a price of Sitagliptin Phosphate bulk with DMF offered by Mankind Pharma
Find a price of Succinylcholine Chloride bulk with DMF offered by Mankind Pharma
Find a price of Sugammadex Sodium bulk with DMF offered by Mankind Pharma
Find a price of Telmisartan bulk with DMF offered by Mankind Pharma
Find a price of Ticagrelor bulk with DMF offered by Mankind Pharma
Find a price of Valsartan bulk with DMF offered by Mankind Pharma
Find a price of EMPAGLIFLOZIN (PROCESS II) bulk with DMF offered by Mankind Pharma
Find a price of Brivaracetam bulk offered by Mankind Pharma
Find a price of Dydrogesterone bulk offered by Mankind Pharma
Find a price of Empagliflozin bulk offered by Mankind Pharma
Find a price of Ensifentrine bulk offered by Mankind Pharma
Find a price of Etoricoxib bulk offered by Mankind Pharma
Find a price of Fezolinetant bulk offered by Mankind Pharma
Find a price of Lasmiditan bulk offered by Mankind Pharma
Find a price of Latanoprostene Bunod bulk offered by Mankind Pharma
Find a price of Lifitegrast bulk offered by Mankind Pharma
Find a price of Netarsudil bulk offered by Mankind Pharma
Find a price of Netarsudil Mesylate bulk offered by Mankind Pharma
Find a price of Obeticholic Acid bulk offered by Mankind Pharma
Find a price of Perfluorohexyloctane bulk offered by Mankind Pharma
Find a price of Resmetirom bulk offered by Mankind Pharma
Find a price of Semaglutide bulk offered by Mankind Pharma
Find a price of Suzetrigine bulk offered by Mankind Pharma
Find a price of Upadacitinib bulk offered by Mankind Pharma
Find a price of Ursodeoxycholic Acid bulk offered by Mankind Pharma
Find a price of Xanomeline bulk offered by Mankind Pharma